These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 6511531

  • 1. Combined treatment of radiation and local injections of misonidazole.
    Hong SS, Abe Y, Kaneta K, Matsuzawa T.
    Int J Radiat Oncol Biol Phys; 1984 Dec; 10(12):2369-73. PubMed ID: 6511531
    [Abstract] [Full Text] [Related]

  • 2. Clinical experience with intravenous misonidazole for carcinoma of the esophagus: results in attempting radiosensitization of each fraction of exposure.
    Schwade JG, Kinsella TJ, Kelly B, Rowland J, Johnston M, Glatstein E.
    Cancer Invest; 1984 Dec; 2(2):91-5. PubMed ID: 6733563
    [Abstract] [Full Text] [Related]

  • 3. The effect of prolonged high dose misonidazole on tumor response to radiation.
    McNally NJ, de Ronde J, Hinchliffe M.
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1281-5. PubMed ID: 6469751
    [Abstract] [Full Text] [Related]

  • 4. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma.
    Ohizumi Y, Murayama C, Maezawa H, Mori T.
    Tokai J Exp Clin Med; 1984 Oct; 9(4):331-7. PubMed ID: 6537042
    [Abstract] [Full Text] [Related]

  • 5. Treatment of bladder carcinoma with irradiation combined with misonidazole.
    Papavasiliou C, Yiogarakis D, Davillas N, Seretakis L, Pappas J, Licourinas M, Theodorou C, Stathopoulos P, Katsoyianni C, Thanos A.
    Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1631-3. PubMed ID: 6358156
    [Abstract] [Full Text] [Related]

  • 6. Palliation of advanced pelvic malignant disease with large fraction pelvic radiation and misonidazole: final report of RTOG phase I/II study.
    Spanos WJ, Wasserman T, Meoz R, Sala J, Kong J, Stetz J.
    Int J Radiat Oncol Biol Phys; 1987 Oct; 13(10):1479-82. PubMed ID: 2442127
    [Abstract] [Full Text] [Related]

  • 7. Nitroheterocyclic compounds as radiation sensitizers and bioreductive drugs.
    Adams GE, Stratford IJ, Bremner JC, Edwards HS, Fielden EM.
    Radiother Oncol; 1991 Oct; 20 Suppl 1():85-91. PubMed ID: 2020774
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical study on radiotherapy in combination with misonidazole].
    Ono K, Takahashi M, Dodo Y, Abe M.
    Nihon Gan Chiryo Gakkai Shi; 1983 Aug 20; 18(5):1189-99. PubMed ID: 6663172
    [No Abstract] [Full Text] [Related]

  • 9. Large fraction irradiation with or without misonidazole in advanced non-oat cell carcinoma of the lung: a phase III randomized trial of the RTOG. Radiation Therapy Oncology Group.
    Simpson JR, Bauer M, Wasserman TH, Perez CA, Emami B, Wiegensberg I, Zinninger M, Durbin LM.
    Int J Radiat Oncol Biol Phys; 1987 Jun 20; 13(6):861-7. PubMed ID: 3034841
    [Abstract] [Full Text] [Related]

  • 10. Clinical trials with hypoxic cell sensitizers: time to retrench or time to push forward?
    Urtasun RC, Coleman CN, Wasserman TH, Phillips TL.
    Int J Radiat Oncol Biol Phys; 1984 Sep 20; 10(9):1691-6. PubMed ID: 6237083
    [Abstract] [Full Text] [Related]

  • 11. Radiosensitizing effect of misonidazole in combination with an inhibitor of glutathione synthesis in murine tumors.
    Ono K, Komuro C, Nishidai T, Shibamoto Y, Tsutsui K, Takahashi M, Abe M.
    Int J Radiat Oncol Biol Phys; 1986 Sep 20; 12(9):1661-6. PubMed ID: 3759592
    [Abstract] [Full Text] [Related]

  • 12. Radiosensitizing drugs in relation to individualized treatment.
    Adams GE.
    Strahlentherapie; 1984 Nov 20; 160(11):688-94. PubMed ID: 6506108
    [No Abstract] [Full Text] [Related]

  • 13. Radiosensitizing effects of misonidazole and SR 2508 on a human melanoma transplanted in nude mice: influence on repair of potentially lethal damage.
    Guichard M, Malaise EP.
    Int J Radiat Oncol Biol Phys; 1982 Nov 20; 8(3-4):465-8. PubMed ID: 6213589
    [Abstract] [Full Text] [Related]

  • 14. Misonidazole combined with large-fraction pelvic irradiation in the treatment of patients with advanced pelvic malignancies. Preliminary report of an ongoing RTOG phase I-II study.
    Meoz RT, Spanos WJ, Doss L, Johnson R, Wasserman TH.
    Am J Clin Oncol; 1983 Aug 20; 6(4):417-22. PubMed ID: 6191560
    [Abstract] [Full Text] [Related]

  • 15. Chemical sensitizers for hypoxic cells: a decade of experience in clinical radiotherapy.
    Dische S.
    Radiother Oncol; 1985 Feb 20; 3(2):97-115. PubMed ID: 3157206
    [Abstract] [Full Text] [Related]

  • 16. Addition of misonidazole, etanidazole, or hyperthermia to treatment with fluosol-DA/carbogen/radiation.
    Teicher BA, Herman TS, Holden SA, Jones SM.
    J Natl Cancer Inst; 1989 Jun 21; 81(12):929-34. PubMed ID: 2525198
    [Abstract] [Full Text] [Related]

  • 17. Hypoxic cell sensitizers and heavy charged particle beams may play complementary roles in killing hypoxic tumor cells.
    Curtis SB, Tenforde TS, Afzal SM.
    Int J Radiat Oncol Biol Phys; 1984 Aug 21; 10(8):1203-5. PubMed ID: 6432747
    [Abstract] [Full Text] [Related]

  • 18. Misonidazole and irradiation in the treatment of high-grade astrocytomas: further report of the Vienna Study Group.
    Stadler B, Kärcher KH, Kogelnik HD, Szepesi T.
    Int J Radiat Oncol Biol Phys; 1984 Sep 21; 10(9):1713-7. PubMed ID: 6090368
    [Abstract] [Full Text] [Related]

  • 19. Combinations of radiation and misonidazole in a murine lung tumor model.
    Siemann DW, Kochanski K.
    Radiat Res; 1981 May 21; 86(2):387-97. PubMed ID: 7232698
    [No Abstract] [Full Text] [Related]

  • 20. Sensitizers and protectors in radiotherapy.
    Brown JM.
    Cancer; 1985 May 01; 55(9 Suppl):2222-8. PubMed ID: 2983876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.